Jasper Therapeutics Inc (JSPR) is lower by Friday morning, with the stock falling -1.89% in pre-market trading to 13. JSPR's short-term technical score of 57 indicates that the stock has traded more bullishly over the last month than 57% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, JSPR ranks higher than 86% of stocks. Jasper Therapeutics Inc has risen 24.41% over the past month, closing at $15.12 on September 24. During this period of time, the stock fell as low as $7.21 and as high as $18.88. JSPR has an average analyst recommendation of Strong Buy. The company has an average price target of $21.00.
JSPR has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on JSPR!